Frontiers in Immunology | Vaccines and Molecular Therapeutics

Review

Published on 10 May 2023

New tools for immunologists: models of lymph node function from cells to tissues

in Vaccines and Molecular Therapeutics

Tochukwu Ozulumba
Alyssa N. Montalbine
Jennifer E. Ortiz-Cárdenas
Rebecca R. Pompano

Frontiers in Immunology

doi 10.3389/fimmu.2023.1183286

14,419 views
25 citations

Editorial

Published on 05 May 2023

Editorial: Non-reactogenic vaccines against Q-fever

in Vaccines and Molecular Therapeutics

Anthony E. Gregory
D. Huw Davies

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196522

2,103 views

Original Research

Published on 05 May 2023

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals

in Vaccines and Molecular Therapeutics

Joana Barros-Martins
Swantje I. Hammerschmidt
Gema Morillas Ramos
Anne Cossmann
Laura Hetzel
Ivan Odak
Miriam Köhler
Metodi V. Stankov
Christiane Ritter
Michaela Friedrichsen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166589

3,578 views
10 citations

Original Research

Published on 05 May 2023

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

in Vaccines and Molecular Therapeutics

Peter Lorenz
Felix Steinbeck
Franz Mai
Emil C. Reisinger
Brigitte Müller-Hilke

Frontiers in Immunology

doi 10.3389/fimmu.2023.1192395

3,048 views
2 citations

Original Research

Published on 03 May 2023

Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

in Vaccines and Molecular Therapeutics

Yanan Tong
Guoxiu Lu
Zhiguo Wang
Shanhu Hao
Guoxu Zhang
Hongwu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1154818

3,193 views
9 citations

Original Research

Published on 02 May 2023

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice

in Vaccines and Molecular Therapeutics

Andrew G. Diamos
Mary D. Pardhe
Melissa H. Bergeman
Aigerim S. Kamzina
Michelle P. DiPalma
Sara Aman
Artemio Chaves
Kenneth Lowe
Jacquelyn Kilbourne
Ian B. Hogue

Frontiers in Immunology

doi 10.3389/fimmu.2023.1085911

3,653 views
1 citation

Original Research

Published on 01 May 2023

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

in Vaccines and Molecular Therapeutics

Fernando Silveira
Mariana Rivera-Patron
Nikita Deshpande
Soledad Sienra
Jackeline Checa
María Moreno
Jose A. Chabalgoity
Samuel P. Cibulski
Mariana Baz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1163858

7,450 views
5 citations

Brief Research Report

Published on 28 Apr 2023

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

in Vaccines and Molecular Therapeutics

Dilip R. Patil
Anita M. Shete
Pragya D. Yadav
Gajanan N. Sapkal
Gururaj R. Deshpande
Himanshu Kaushal
Sreelekshmy Mohandas
Siddharam Fulari
Rajlaxmi Jain
Ajay Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1161571

2,416 views

Original Research

Published on 27 Apr 2023

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

in Vaccines and Molecular Therapeutics

Natalia Egri
Hugo Calderón
Robert Martinez
Mario Vazquez
Verónica Gómez-Caverzaschi
Mariona Pascal
Olga Araújo
Manel Juan
Europa Azucena González-Navarro
José Hernández-Rodríguez

Frontiers in Immunology

doi 10.3389/fimmu.2023.1146841

3,928 views
13 citations

Original Research

Published on 27 Apr 2023

Parents‘ and healthcare professionals’ perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application

in Vaccines and Molecular Therapeutics

Lama Al Bashir
Aniza Ismail
Syed Mohamed Aljunid

Frontiers in Immunology

doi 10.3389/fimmu.2023.1052450

2,758 views

Original Research

Published on 27 Apr 2023

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

in Vaccines and Molecular Therapeutics

Jingjing Gao
Linlin Huang
Shuquan Luo
Ruijie Qiao
Fanglei Liu
Xin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1124695

3,396 views
6 citations

Hypothesis and Theory

Published on 26 Apr 2023

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors

in Vaccines and Molecular Therapeutics

Piotr Rzymski

Frontiers in Immunology

doi 10.3389/fimmu.2023.1183258

4,681 views
12 citations

Original Research

Published on 26 Apr 2023

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

in Vaccines and Molecular Therapeutics

Anna Morena D’Alise
Linda Nocchi
Irene Garzia
Laura Seclì
Luigia Infante
Fulvia Troise
Gabriella Cotugno
Simona Allocca
Giuseppina Romano
Armin Lahm

Frontiers in Immunology

doi 10.3389/fimmu.2023.1156714

3,685 views
6 citations

Study Protocol

Published on 26 Apr 2023

Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors

in Vaccines and Molecular Therapeutics

Eva Baier
Peter Korsten
Arne Strauß
Kai-Martin Thoms
Tobias Overbeck
Philipp Ströbel
Björn Tampe

Frontiers in Immunology

doi 10.3389/fimmu.2023.1140677

1,463 views

Review

Published on 24 Apr 2023

mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV

in Vaccines and Molecular Therapeutics

Laura Matarazzo
Paulo J. G. Bettencourt

Frontiers in Immunology

doi 10.3389/fimmu.2023.1172691

16,119 views
42 citations

Review

Published on 21 Apr 2023

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

in Vaccines and Molecular Therapeutics

Vivek P. Chavda
Nidhi Raval
Soham Sheta
Lalitkumar K. Vora
Fatma Elrashdy
Elrashdy M. Redwan
Vladimir N. Uversky
Yavuz Nuri Ertas

Frontiers in Immunology

doi 10.3389/fimmu.2023.1064459

5,186 views
6 citations